These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12387361)

  • 41. Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats.
    Bajgar J
    Acta Medica (Hradec Kralove); 2008; 51(4):223-8. PubMed ID: 19453088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
    Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
    Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs.
    Philippens IH; Melchers BP; Olivier B; Bruijnzeel PL
    Pharmacol Biochem Behav; 2000 Jan; 65(1):175-82. PubMed ID: 10638651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
    Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
    Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful pretreatment/therapy of soman, sarin and VX intoxication.
    Lennox WJ; Harris LW; Anderson DR; Solana RP; Murrow ML; Wade JV
    Drug Chem Toxicol; 1992; 15(4):271-83. PubMed ID: 1459040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of physostigmine as a pretreatment for organophosphate poisoning.
    Miller SA; Blick DW; Kerenyi SZ; Murphy MR
    Pharmacol Biochem Behav; 1993 Feb; 44(2):343-7. PubMed ID: 8446666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
    Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
    Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats.
    Bloch-Shilderman E; Rabinovitz I; Egoz I; Yacov G; Allon N; Nili U
    Arch Toxicol; 2018 Feb; 92(2):873-892. PubMed ID: 29127449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX.
    Graham JR; Wright BS; Rezk PE; Gordon RK; Sciuto AM; Nambiar MP
    Inhal Toxicol; 2006 Jun; 18(7):493-500. PubMed ID: 16603480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys.
    Koplovitz I; Gresham VC; Dochterman LW; Kaminskis A; Stewart JR
    Arch Toxicol; 1992; 66(9):622-8. PubMed ID: 1482284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of scopolamine and phencynonate on organophosphorus nerve agent-induced seizure activity, neuropathology and lethality.
    Shih TM; Koenig JA; Acon Chen C
    Toxicol Mech Methods; 2019 Jun; 29(5):322-333. PubMed ID: 30558458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal of cardiac vagal effects of physostigmine by adjunctive muscarinic blockade.
    Winter J; Cook AR; Patient DH; Emmett SR; Tattersall J; Shattock MJ
    Neurotoxicology; 2016 Dec; 57():174-182. PubMed ID: 27693445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
    Herkert NM; Thiermann H; Worek F
    Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects.
    Philippens IH; Busker RW; Wolthuis OL; Olivier B; Bruijnzeel PL; Melchers BP
    Pharmacol Biochem Behav; 1998 Apr; 59(4):1061-7. PubMed ID: 9586868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of LCt(50)s in anesthetized rats exposed to aerosolized nerve agents.
    Collins JL; Peng X; Lee R; Witriol A; Pierre Z; Sciuto AM
    Toxicol Mech Methods; 2013 Feb; 23(2):127-33. PubMed ID: 22978758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological antagonism of lethal effects induced by O-isobutyl S-[2-(diethylamino)ethyl]methylphosphonothioate.
    Chang FC; Hoffman BE; DeBus S
    Drug Chem Toxicol; 2002 Aug; 25(3):321-37. PubMed ID: 12173252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs.
    Philippens IH; Joosen MJ; Vanwersch RA
    Pharmacol Biochem Behav; 2005 Sep; 82(1):125-32. PubMed ID: 16126267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicology; 1999 Jun; 134(2-3):169-78. PubMed ID: 10403635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
    Harris LW; Anderson DR; Pastelak AM; Vanderpool B
    Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats.
    Bloch-Shilderman E; Yacov G; Cohen L; Egoz I; Gutman H; Gez R; Rabinovitz I; Nili U
    Arch Toxicol; 2019 May; 93(5):1365-1384. PubMed ID: 30729277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.